CCNU in brain tumours.
CCNU, a nitrosourea compound, has been found effective in the management of both primary and secondary tumours of the brain. It is proposed to carry out an investigation comparing radiotherapy alone with radiotherapy and CCNU combined, in cerebral gliomata.
D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002528:Cerebellar Neoplasms / Q000188:drug therapy; D002675:Child, Preschool; D005260:Female; D005910:Glioma / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use*; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy
D009607:Nitrosourea Compounds; D008130:Lomustine